JYNT
The Joint Corp.
JYNT offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
LLY
Eli Lilly and Company
LLY has the edge over JYNT overall, supported by stronger fundamentals.
JYNT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
JYNT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
JYNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $6.69 | — |
| Current | 33x | $6.69 | — |
| Cheap | 44x | $8.80 | +32% |
| Fair | 70x | $13.93 | +108% |
| Expensive | 110x | $22.06 | +230% |
Historical ranges are pointers, not guarantees.
JYNT has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
JYNT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect JYNT's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over JYNT on the outlook, with more favorable revenue expectations.
JYNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +63% |
| Q3 2026 | $0.20 | +54% |
| Q2 2026 | $0.27 | +$0.41 |
| Q1 2026 | $0.23 | +$0.62 |
| Q4 2025 | $0.20 | +$0.59 |
| Q3 2025 | $0.13 | +$1.26 |
| Q2 2025 | -$0.14 | +$0.83 |
| Q1 2025 | -$0.39 | +$0.36 |
| Q4 2024 | -$0.39 | +$0.26 |
JYNT's earnings per share have fallen from their peak: $0.20 over the past year, against $1.19 in late 2021.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
JYNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.6M | +1.3% |
| Q2 2026 | $15.2M | +14% |
| Q1 2026 | $14.8M | +13% |
| Q4 2025 | $15.2M | +3.1% |
| Q3 2025 | $13.4M | -56% |
| Q2 2025 | $13.3M | -56% |
| Q1 2025 | $13.1M | -56% |
| Q4 2024 | $14.7M | -52% |
JYNT's revenue has grown year over year for four quarters in a row: $14M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.8% | +8.6 points |
| Q2 2026 | -2.4% | +6.2 points |
| Q1 2026 | 5.9% | +11 points |
| Q4 2025 | 4.9% | -0.6 points |
| Q3 2025 | 1.2% | +12 points |
| Q2 2025 | -8.6% | +3 points |
| Q1 2025 | -5.2% | -8.9 points |
| Q4 2024 | 5.5% | +6 points |
JYNT's operating margin was 9.8% last quarter, up 8.6 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over JYNT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over JYNT on profitability, with a higher operating margin.
JYNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$508.6K | -135% |
| Q2 2026 | $1.9M | +432% |
| Q1 2026 | -$1.7M | +$2.3M |
| Q4 2025 | $2.5M | -34% |
| Q3 2025 | $1.5M | -55% |
| Q2 2025 | $363.6K | +$1.6M |
| Q1 2025 | -$4M | -267% |
| Q4 2024 | $3.8M | +73% |
JYNT usually generates cash, though not every quarter: the latest was −$508,635, but it generated $2M over the past year.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over JYNT on cash flow, with more consistent year-over-year improvement.
JYNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -215K shares |
| 1 year | -8.9% | -1.4M shares |
| 3 years | -6.6% | -984K shares |
| 5 years | -6.3% | -938K shares |
| Available history | -3% | -436K shares |
JYNT has the edge over LLY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.8M |
| Q2 2026 | $676,810 |
| Q1 2026 | $1.1M |
| Q4 2025 | $9M |
| Q3 2025 | $2.3M |
| Q2 2025 | — |
| Q1 2025 | $8,440 |
| Q4 2024 | — |
JYNT spent $15M buying back its own shares over the past year, about six times what it spent the year before.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has 893M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
JYNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.5x | Net Cash |
| Q2 2026 | -7.1x | Net Cash |
| Q1 2026 | -8.9x | Net Cash |
| Q4 2025 | -31.2x | Net Cash |
| Q3 2025 | -39.9x | Net Cash |
| Q3 2024 | -180.9x | Net Cash |
| Q2 2024 | -5.0x | Net Cash |
| Q1 2024 | -2.5x | Net Cash |
JYNT has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
JYNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 9.3 | Oversold |
JYNT's weekly RSI is 32 (neutral) and its Stochastic is 9 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
JYNT PE vs Healthcare Sector
| Metric | JYNT | Sector median | Relative |
|---|---|---|---|
| PE | 33x | 26x | 29% above |
| PE % | 5 | 29 | 24 pts below |
JYNT has the edge over LLY on valuation relative to its sector.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
JYNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.17 | 6.7% below |
| 20 week MA | $7.96 | 16% below |
| 50 week MA | $8.54 | 22% below |
| 100 week MA | $9.49 | 30% below |
| 200 week MA | $10.9 | 39% below |
JYNT is in a downtrend: it's below all five of its weekly moving averages, and 39% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over JYNT on trend strength, trading above more of its moving averages.
JYNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.3 | $25.5 | +57% |
| 2021 | $25.5 | $64.7 | +153% |
| 2022 | $64.7 | $15.1 | -77% |
| 2023 | $15.1 | $9.61 | -36% |
| 2024 | $9.61 | $9.90 | +3% |
| 2025 | $9.90 | $8.76 | -12% |
| 2026 YTD | $8.76 | $6.69 | -24% |
JYNT's yearly returns have swung widely, from +153% in 2021 to −77% in 2022. It's down 24% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over JYNT on returns for 2026, with the stronger performance.